Document And Entity Information
Document And Entity Information - shares | 6 Months Ended | |
Jun. 30, 2021 | Jul. 30, 2021 | |
Document Information Line Items | ||
Entity Registrant Name | SPINE INJURY SOLUTIONS, INC. | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 20,240,882 | |
Amendment Flag | false | |
Entity Central Index Key | 0001066764 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Jun. 30, 2021 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q2 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 000-27407 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 98-0187705 | |
Entity Address, Address Line One | 5151 Mitchelldale Suite A2 | |
Entity Address, City or Town | Houston | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 77092 | |
City Area Code | 713 | |
Local Phone Number | 521-4220 | |
Title of 12(b) Security | None | |
Entity Interactive Data Current | Yes |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Jun. 30, 2021 | Dec. 31, 2020 |
Current assets: | ||
Cash and cash equivalents | $ 15,934 | $ 41,655 |
Accounts receivable, net | 48,887 | 232,244 |
Prepaid assets | 7,500 | 0 |
Total current assets | 72,321 | 273,899 |
Accounts receivable, net of allowance for doubtful accounts of $559,007 and $585,257 at June 30, 2021 and December 31,2020, respectively | 0 | 0 |
Property and equipment, net | 3,749 | 10,959 |
Total assets | 76,070 | 284,858 |
Current liabilities: | ||
Note payable to stockholder | 450,000 | 490,000 |
Accounts payable and accrued liabilities | 18,863 | 43,288 |
Total current liabilities | 468,863 | 533,288 |
Commitments and contingencies | ||
Stockholders’ deficit: | ||
Preferred stock; $0.001 par value, 10,000,000 shares authorized no shares issued and outstanding | 0 | 0 |
Common stock: $0.001 par value, 250,000,000 shares authorized, 20,240,882 shares issued and outstanding at June 30, 2021 and December 31, 2020 | 20,241 | 20,241 |
Additional paid-in capital | 19,869,511 | 19,869,511 |
Accumulated deficit | (20,282,545) | (20,138,182) |
Total stockholders’ deficit | (392,793) | (248,430) |
Total liabilities and stockholders’(deficit | $ 76,070 | $ 284,858 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) | Jun. 30, 2021 | Dec. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance for doubtful accounts (in Dollars) | $ 559,007 | $ 585,257 |
Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock; shares issued | 0 | 0 |
Common stock: par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Common stock: shares authorized | 250,000,000 | 250,000,000 |
Common stock: shares issued | 20,240,882 | 20,240,882 |
Common stock: shares outstanding | 20,240,882 | 20,240,882 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2021 | Jun. 30, 2020 | Jun. 30, 2021 | Jun. 30, 2020 | |
Income Statement [Abstract] | ||||
Net service revenues | $ 3,087 | $ 35,500 | $ 7,905 | $ 65,448 |
Lease revenues | 26,073 | 17,922 | 52,146 | 43,795 |
Total revenues | 29,160 | 53,422 | 60,051 | 109,243 |
Cost of providing services | 0 | 0 | 0 | 0 |
Gross profit | 29,160 | 53,422 | 60,051 | 109,243 |
Operating, general and administrative expenses | 100,103 | 179,284 | 190,774 | 263,732 |
Loss from operations | (70,943) | (125,862) | (130,723) | (154,489) |
Other income and (expense): | ||||
Other income | 48 | 260 | 50 | 452 |
Interest expense | (6,925) | (4,667) | (13,690) | (12,809) |
Total other income and (expense) | (6,877) | (4,407) | (13,640) | (12,357) |
Net loss | $ (77,820) | $ (130,269) | $ (144,363) | $ (166,846) |
Basic/ diluted (in Dollars per share) | $ 0 | $ (0.01) | $ (0.01) | $ (0.01) |
Weighted average shares outstanding: | ||||
Basic/ diluted (in Shares) | 20,240,882 | 20,240,882 | 20,240,882 | 20,240,882 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 6 Months Ended | |
Jun. 30, 2021 | Jun. 30, 2020 | |
Cash flows from operating activities: | ||
Net loss | $ (144,363) | $ (166,846) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Provision for bad debts, net of recoveries | 0 | 26,398 |
Depreciation expense | 7,210 | 7,210 |
Changes in operating assets and liabilities: | ||
Accounts receivable, net | 183,357 | 485,055 |
Prepaid expenses and other assets | (7,500) | 10,308 |
Accounts payable and accrued liabilities | (24,425) | (32,298) |
Net cash provided by operating activities | 14,279 | 329,827 |
Cash flows from financing activities: | ||
Repayment of note payable to stockholder | (40,000) | 0 |
Proceeds of Paycheck Protection Program loan | 0 | 64,097 |
Payments of note payable | 0 | (415,000) |
Net cash used in financing activities | (40,000) | (350,903) |
Net decrease in cash and cash equivalents | (25,721) | (21,076) |
Cash and cash equivalents at beginning of period | 41,655 | 110,587 |
Cash and cash equivalents at end of period | 15,934 | 89,511 |
Supplementary disclosure of cash flow information: | ||
Interest paid | $ 13,690 | $ 12,809 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balances at Dec. 31, 2019 | $ 20,241 | $ 19,869,511 | $ (19,480,788) | $ 48,964 |
Balances (in Shares) at Dec. 31, 2019 | 20,240,882 | |||
Net loss | (36,577) | (36,577) | ||
Balances at Mar. 31, 2020 | $ 20,241 | 19,869,511 | (19,877,365) | 12,387 |
Balances (in Shares) at Mar. 31, 2020 | 20,240,882 | |||
Balances at Dec. 31, 2019 | $ 20,241 | 19,869,511 | (19,480,788) | 48,964 |
Balances (in Shares) at Dec. 31, 2019 | 20,240,882 | |||
Net loss | (166,846) | |||
Balances at Jun. 30, 2020 | $ 20,241 | 19,869,511 | (20,007,634) | (117,882) |
Balances (in Shares) at Jun. 30, 2020 | 20,240,882 | |||
Balances at Mar. 31, 2020 | $ 20,241 | 19,869,511 | (19,877,365) | 12,387 |
Balances (in Shares) at Mar. 31, 2020 | 20,240,882 | |||
Net loss | (130,269) | (130,269) | ||
Balances at Jun. 30, 2020 | $ 20,241 | 19,869,511 | (20,007,634) | (117,882) |
Balances (in Shares) at Jun. 30, 2020 | 20,240,882 | |||
Balances at Dec. 31, 2020 | $ 20,241 | 19,869,511 | (20,138,182) | $ (248,430) |
Balances (in Shares) at Dec. 31, 2020 | 20,240,882 | 20,240,882 | ||
Net loss | (66,543) | $ (66,543) | ||
Balances at Mar. 31, 2021 | $ 20,241 | 19,869,511 | (20,204,725) | (314,973) |
Balances (in Shares) at Mar. 31, 2021 | 20,240,882 | |||
Balances at Dec. 31, 2020 | $ 20,241 | 19,869,511 | (20,138,182) | $ (248,430) |
Balances (in Shares) at Dec. 31, 2020 | 20,240,882 | 20,240,882 | ||
Net loss | $ (144,363) | |||
Balances at Jun. 30, 2021 | $ 20,241 | 19,869,511 | (20,282,545) | $ (392,793) |
Balances (in Shares) at Jun. 30, 2021 | 20,240,882 | 20,240,882 | ||
Balances at Mar. 31, 2021 | $ 20,241 | 19,869,511 | (20,204,725) | $ (314,973) |
Balances (in Shares) at Mar. 31, 2021 | 20,240,882 | |||
Net loss | (77,820) | (77,820) | ||
Balances at Jun. 30, 2021 | $ 20,241 | $ 19,869,511 | $ (20,282,545) | $ (392,793) |
Balances (in Shares) at Jun. 30, 2021 | 20,240,882 | 20,240,882 |
DESCRIPTION OF BUSINESS
DESCRIPTION OF BUSINESS | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
Nature of Operations [Text Block] | NOTE 1. DESCRIPTION OF BUSINESS Spine Injury Solutions Inc. was incorporated under the laws of Delaware on March 4, 1998. We changed our name from Spine Pain Management Inc. to Spine Injury Solutions, Inc. on October 1, 2015. We are a technology, marketing, billing, and collection company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons and other healthcare providers for necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our goal is to become a leader in providing technology and monetizing services to spine and orthopedic surgeons and other healthcare providers to facilitate proper treatment of their injured clients. By monetizing the providers accounts receivable, which includes diagnostic testing and non-invasive surgical care, patients are not unnecessarily delayed or prevented from obtaining needed treatment. By facilitating early treatment through affiliated doctors, we believe that health conditions can be prevented from escalating and injured victims can be quickly placed on the road to recovery. Through our affiliate system, we facilitate spine surgeons, orthopedic surgeons and other healthcare providers to provide reasonable, necessary, and appropriate treatments to patients with musculo-skeletal spine injuries. We assist the centers that provide the spine diagnostic injections and treatment and pay the doctors a fee for the medical procedures they performed. After a patient is billed for the procedures performed by the affiliated doctor, we take control of the patients’ unpaid bill and oversee collection. In most instances, the patient is a plaintiff in an accident case, where the patient is represented by an attorney. Typically, the defendant (and/or the insurance company of the defendant) in the accident case pays the patient’s bill upon settlement or final judgment of the accident case. The payment to us is made through the attorney of the patient. In most cases, we must agree to the settlement price and the patient must sign off on the settlement. Once we are paid, the patient’s attorney can receive payment for his or her legal fee. During the fourth quarter of 2018, the decision was made to discontinue funding future medical procedures due to our cash position, and we have not funded any procedures in 2021 and 2020 and will not do so unless we can access additional capital. However, we continue to actively pursue the collection of previously funded procedures. Without additional funding, there is no guarantee that we can continue as a going concern. We own a patented device and process by which a video recording system is attached to a fluoroscopic x-ray machine, the “four camera technology,” which we believe can attract additional physicians and patients as well as provide us with additional revenue streams with our new programs designed to assist in treatment documentation. We have refined the technology, through research and development, resulting in a fully commercialized Quad Video Halo System 3.0. Using this technology, diagnostic and treatment procedures are recorded from four separate video feeds that capture views from both inside and outside the body, and a video is made which is given to the patient’s representative to verify the treatment received. In September 2014, we created a wholly owned subsidiary, Quad Video Halo, Inc. The purpose of this entity is to hold certain company assets affiliated with the QVH units. |
GOING CONCERN CONSIDERATIONS
GOING CONCERN CONSIDERATIONS | 6 Months Ended |
Jun. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Substantial Doubt about Going Concern [Text Block] | NOTE 2. GOING CONCERN CONSIDERATIONS Since our inception in 1998, until commencement of our spine injury diagnostic operations in August, 2009, our expenses substantially exceeded our revenue, resulting in continuing losses and an accumulated deficit from operations of $15,004,698 as of December 31, 2009. Since that time, our accumulated deficit has increased $5,277,847 to $20,282,545 as of June 30, 2021. Presently, we are trying to limit operating expenses to the greatest extent possible. If in the future we decide to increase our service development, marketing efforts and/or brand building activities, we will need to increase our operating expenses and our general and administrative functions to support such growth in operations. No such growth in operations is presently planned. We are also actively seeking a private company with which to enter into a strategic business transaction, including a merger; however, we cannot predict the ultimate outcome of our efforts. Our continued existence is dependent upon our ability to successfully merge with a financially viable company, or our ability to increase revenue from services and obtain additional capital from borrowing and sales of our equity securities, as needed, to fund our operations. There is no assurance that additional capital can be obtained or that it can be obtained on terms that are favorable to us and our existing stockholders. Any expectation of future profitability is dependent upon our ability to expand and develop our business, of which there can be no assurances. During the fourth quarter of 2018, the decision was made to discontinue our involvement in future medical procedures due to our limited cash position, which hampers our ability to pay back existing debt to a current director and stockholder (see Note 5—Term Loan). We were not involved in any procedures in 2021 and 2020, and will not resume procedures unless we can access additional capital. The service revenue we previously earned has resulted in longer settlement times and a slowdown in cash collections. Additionally, our efforts to establish a market for the Quad Video Halo has not met our expectations, and we have cut back its development and operations. If we are unable to access additional capital in the near future, these recent developments could have a material negative impact on our financial performance and could have a material adverse effect on our results of operations and financial condition. We are actively pursuing a merger with a private company where they become the controlling company. We find this the best course of action for our stockholders. Further, the COVID-19 pandemic has made it difficult for us to collect our accounts receivable, as attorney and medical offices are closed resulting in delayed settlements and medical procedures being canceled, which affects our lease revenue. We are uncertain how this pandemic will affect our ability to collect in the future or its overall effect on our lease revenue. |
CRITICAL ACCOUNTING POLICIES
CRITICAL ACCOUNTING POLICIES | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | NOTE 3. CRITICAL ACCOUNTING POLICIES The following are summarized accounting policies considered to be critical by our management: Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures, normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. Nevertheless, we believe that the disclosures are adequate to make the information presented not misleading. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our 2020 Annual Report as filed on Form 10-K. In the opinion of management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position with respect to the interim condensed consolidated financial statements and the results of its operations for the interim period ended June 30, 2021, have been included. The results of operations for interim periods are not necessarily indicative of the results for a full year. Basis of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Spine Injury Solutions, Inc. and its wholly owned subsidiary, Quad Video Halo, Inc. All material intercompany balances of transactions have been eliminated upon consolidation. Accounting Method Our financial statements are prepared using the accrual basis of accounting in accordance with U.S. GAAP. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of our condensed consolidated financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of our financial position and results of operations. Revenue Recognition The Company’s accounting for revenues is governed by two accounting standards. The Company’s service and product sale revenue are accounted for under ASC 606, Revenue from Contracts with Customers. Additionally, the Company’s QVH rental revenues are accounted for under ASC 842, Leases. Service and Product Sale Revenue Recognition Historically, our net revenues included service revenues that arose from the delivery of medical diagnostic services provided to patients by medical professionals at spine injury diagnostic centers, only after the patients completed and signed required medical and financial paperwork. Service revenues were recorded as net patient service revenues based on variable consideration elements further described below and in Note 4. While we did collect 100% of the accounts on certain patients, our historical collection rate was used to estimate the variable consideration expected and is reflected in the carrying balance of accounts receivable and service revenue recorded. A discount rate of 48%, based on payment history, was used to reduce revenue to 52% of Current Procedural Terminology code rates (“CPT” codes are numbers assigned to every task and service a medical practitioner may provide to a patient including medical, surgical and diagnostic services. CPT codes are developed, maintained and copyrighted by the American Medical Association). Patients were billed at the normal billing amount, based on national averages, for a particular CPT code procedure during the year ended December 31, 2018 and prior years. We recorded no revenue related to medical diagnostic services provided during the three or six months ended June 30, 2021 and 2020, and revenue presented represents adjustments of variable consideration received for procedures performed in years prior to 2019. Service revenue and corresponding accounts receivable are recognized by reference to “net revenue” and “accounts receivable, net” which is defined as gross amounts billed using CPT codes (“gross revenue”) less account discounts that are expected to result when individual cases are ultimately settled, which is the variable consideration associated with this revenue stream. Lease Revenue Rental revenues from operating leases are recognized on a straight-line basis over the term of the lease. Rental billings for periods extending beyond period-end are recorded as deferred income and are recognized in the period earned. For the QVH Leases, rental related services revenues for support, maintenance and video processing, delivery, and installation are lease related because the payments are considered minimum lease payments that are an integral part of the negotiated lease agreement with the customer. These revenues are recognized on a straight-line basis over the term of the lease. As of June 30, 2021, the Company’s leases consisted solely of operating leases. As stated previously, we are uncertain on the effects of the COVID-19 pandemic on our lease revenue going forward. Fair Value of Financial Instruments Cash, accounts receivable, accounts payable and accrued liabilities, and notes payable, as reflected in the condensed consolidated financial statements, approximates fair value. Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect these estimates. Cash and Cash Equivalents Cash and cash equivalents consist of liquid investments with original maturities of three months or less. Cash equivalents are stated at cost, which approximates fair value. We maintain cash and cash equivalents in banks which at times may exceed federally insured limits. We have not experienced any losses on these deposits. Long-Lived Assets We periodically review and evaluate long-lived assets, including intangible assets, when events and circumstances indicate that the carrying amount of these assets may not be recoverable. In performing our review for recoverability, we estimate the future cash flows expected to result from the use of such assets and its eventual disposition. If the sum of the expected undiscounted future operating cash flows is less than the carrying amount of the related assets, an impairment loss is recognized in the consolidated statements of operations. Measurement of the impairment loss is based on the excess of the carrying amount of such assets over the fair value calculated using discounted expected future cash flows. As of and for the six and three months ended June 30, 2021, no impairment of long-lived assets was determined to have occurred. Concentrations of Credit Risk Assets that expose us to credit risk consist primarily of accounts receivable. Our accounts receivable are from a diversified customer base and, therefore, we believe the concentration of credit risk is minimal. We evaluate the creditworthiness of customers before any services are provided. We record a discount based on the nature of our business, collection trends, and an assessment of our ability to fully realize amounts billed for services. Additionally, we have established an allowance for doubtful accounts in the amount of $559,007 and $585,257, at June 30, 2021 and December 31, 2020, respectively. Stock Based Compensation We account for the measurement and recognition of compensation expense for all share-based payment awards made to employees and directors, including employee stock options, based on estimated fair values. Under authoritative guidance issued by the Financial Accounting Standards Board (“FASB”), companies are required to estimate the fair value or calculated value of share-based payment awards on the date of grant using an option-pricing model. The value of awards that are ultimately expected to vest is recognized as expense over the requisite service periods in our condensed consolidated statements of operations. We use the Black-Scholes Option Pricing Model to determine the fair-value of stock-based awards. During the three and six months ended June 30, 2021 and 2020, we did not issue any of our common stock in exchange for services. Income Taxes We account for income taxes in accordance with the liability method. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax basis. We establish a valuation allowance to the extent that it is more likely than not that deferred tax assets will not be utilized against future taxable income. Uncertain Tax Positions Accounting Standards Codification “ASC” Topic 740-10-25 defines the minimum threshold a tax position is required to meet before being recognized in the financial statements as “more likely than not” (i.e., a likelihood of occurrence greater than fifty percent). Under ASC Topic 740-10-25, the recognition threshold is met when an entity concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination by the relevant taxing authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard or are resolved through negotiation or litigation with the taxing authority, or upon expiration of the statute of limitations. De-recognition of a tax position that was previously recognized occurs when an entity subsequently determines that a tax position no longer meets the more likely than not threshold of being sustained. We are subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, we may incur additional tax expense based upon the outcomes of such matters. In addition, when applicable, we will adjust tax expense to reflect our ongoing assessments of such matters which require judgment and can materially increase or decrease our effective rate as well as impact operating results. Under ASC Topic 740-10-25, only the portion of the liability that is expected to be paid within one year is classified as a current liability. As a result, liabilities expected to be resolved without the payment of cash (e.g. resolution due to the expiration of the statute of limitations) or are not expected to be paid within one year are not classified as current. Estimated interest and penalties, if any, are recognized as income tax expense and tax credits as a reduction in income tax expense. For the three and six months ended June 30, 2021 and 2020, we recognized no estimated interest or penalties as income tax expense. Legal Costs and Contingencies In the normal course of business, we incur costs to hire and retain external legal counsel to advise us on regulatory, litigation and other matters. We expense these costs as the related services are received. If a loss is considered probable and the amount can be reasonably estimated, we recognize an expense for the estimated loss. If we have the potential to recover a portion of the estimated loss from a third party, we make a separate assessment of recoverability and reduce the estimated loss if recovery is also deemed probable. Net Loss per Share Net loss per common share is presented in accordance with ASC Topic 260, “Earnings per Share,” for all periods presented. During the three and six months ended June 30, 2021 and 2020, common stock equivalents from outstanding stock options, warrants and convertible debt have been excluded from the calculation of the diluted earnings (loss) per share in the condensed consolidated statements of operations, because all such securities were anti-dilutive. The loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the periods. Recent Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU No. 2016-13 eliminates the probable initial recognition threshold in current U.S. GAAP and, instead, requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. In addition, ASU No. 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU No. 2016-13 was initially effective for annual periods beginning after December 15, 2020, with early application permitted in annual periods beginning after December 15, 2018. In November 2019, the FASB issued ASU 2019-10 which amended the effective date for small reporting companies to fiscal years beginning after December 15, 2022. The amendments of ASU No. 2016-13 should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management is currently evaluating the future impact of ASU No. 2016-13 on the Company’s consolidated financial position, results of operations and disclosures. |
ACCOUNTS RECEIVABLE
ACCOUNTS RECEIVABLE | 6 Months Ended |
Jun. 30, 2021 | |
Receivables [Abstract] | |
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] | NOTE 4. ACCOUNTS RECEIVABLE The patients are billed by the healthcare provider based on Current Procedural Terminology (“CPT”) codes for the medical procedure performed. CPT codes are numbers assigned to every task and service a medical practitioner may provide to a patient including medical, surgical and diagnostic services. CPT codes are developed, maintained and copyrighted by the American Medical Association. Patients are billed at the normal billing amount, based on national averages, for a particular CPT code procedure. Revenue and corresponding accounts receivable are recognized by reference to “net revenue” and “accounts receivable, net” which is defined as gross amounts billed using CPT codes less account discounts that are expected to result when individual cases are ultimately settled. While we do collect 100% of the accounts on some patients, our historical collection rate is used to calculate the carrying balance of the accounts receivable and the estimated revenue to be recorded. A discount rate of 48%, based on payment history, was used to reduce revenue to 52% of CPT code billings (“gross revenue”) during the six months ended June 30, 2021. The patients who receive medical services at the diagnostic centers are typically patients involved in auto accidents or work injuries. The patient completes and signs medical and financial paperwork, which includes an acknowledgement of the patient’s responsibility of payment for the services provided. Additionally, the paperwork should include an assignment of benefits. The timing of collection of receivables varies depending on patient sources of payment. Historical experience, through 2018, demonstrated that the collection period for individual cases may extend for two years or more. Our credit policy has been established based upon extensive experience by management in the industry and has been determined to ensure that collectability is reasonably assured. Payment for services are primarily made to us by a third party and the credit policy includes terms of net 240 days for collections; however, collections occur upon settlement or judgment of cases. As of June 30, 2021 and December 31, 2020, we determined an allowance for uncollectable accounts of $559,007 and $585,257, respectively, was needed for those customer accounts whose collections appear doubtful. |
TERM LOAN
TERM LOAN | 6 Months Ended |
Jun. 30, 2021 | |
Debt Disclosure [Abstract] | |
Debt Disclosure [Text Block] | NOTE 5. TERM LOAN On August 31, 2020, Peter L. Dalrymple, a member of our board of directors, paid-off in full the outstanding balance of a term loan we had with Wells Fargo Bank, N.A. As consideration for Mr. Dalrymple paying off the term loan on our behalf, we issued Mr. Dalrymple a $610,000 one-year secured promissory note. The secured promissory note bears interest of 6% per year with monthly payments of interest only due until maturity, when all unpaid interest and principal is due. This note is collateralized by all of our accounts receivable and a pledge of the stock of our wholly owned subsidiary, Quad Video Halo, Inc. The secured promissory note balance was $450,000 and $490,000 at June 30, 2021 and December 31, 2020, respectively. During the three and six months ended June 30, 2021, the Company recorded $6,925 and $13,690, respectively, in interest expense on the Dalrymple note, representing all interest due through that date. |
STOCKHOLDERS' EQUITY
STOCKHOLDERS' EQUITY | 6 Months Ended |
Jun. 30, 2021 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 6. STOCKHOLDERS EQUITY The total number of authorized shares of our common stock is 250,000,000 shares, $0.001 par value per share. As of June 30, 2021, there were 20,240,882 common shares issued and outstanding. We did not issue any shares of common stock for the three and six months ended June 30, 2021. On January 19, 2021, our stockholders approved the filing of an amendment to our certificate of incorporation to increase our authorized common stock from 50,000,000 to 250,000,000 shares, and to authorize 10,000,000 shares of preferred stock, par value of $0.001 per share. Such amendment was filed on January 20, 2021. Such amendment was filed on January 20, 2021. We did not issue any shares of common stock or preferred stock for the three and six months ended June 30, 2021. |
INCOME TAXES
INCOME TAXES | 6 Months Ended |
Jun. 30, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | NOTE 7. INCOME TAXES We have not made a provision for income taxes for the three and six months ended June 30, 2021 or 2020, which reflects our valuation allowance established against our benefits from net operating loss carryforwards. |
LEASE REVENUES
LEASE REVENUES | 6 Months Ended |
Jun. 30, 2021 | |
Disclosure Text Block [Abstract] | |
Lessor, Operating Leases [Text Block] | NOTE 8. LEASE REVENUES The Company’s QVH unit rentals are governed by agreements that detail the lease terms and conditions. The determination of whether these contracts with customers contain a lease generally does not require significant judgement. The Company accounts for these rentals as operating leases. These leases do not include material amounts of variable payments and the Company has made the accounting policy election to exclude all taxes assessed by a governmental authority. The Company provides an option of the lessee to purchase the rented equipment upon the termination of the lease for the as then fair market value; however, the Company has not generated material revenue from sales of equipment under such options. Initial lease terms vary in length based upon customer needs and generally range from twelve to thirty-six months. Customers have the option to keep equipment on rent beyond the initial lease term on a one-year successive term that auto renews unless canceled by the customer. All of the Company’s rental products have long useful lives relative to the typical rental term with the original investment typically recovered in approximately five years. The rental products are typically rented for a majority of the time owned and a significant portion of the original investment is recovered when sold from inventory. The Company’s lease agreements do not contain residual value guarantees or restrictive covenants. All of the Company’s outstanding lease contracts as of June 30, 2021, are scheduled to mature during the remainder of 2021 with expected operating lease payments to be received totaling approximately $16,000. Included in property and equipment, net, as of June 30, 2021 and December 31, 2020 is equipment available for rent in the amount of $3,749 and $10,959, respectively. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 6 Months Ended |
Jun. 30, 2021 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures, normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. Nevertheless, we believe that the disclosures are adequate to make the information presented not misleading. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our 2020 Annual Report as filed on Form 10-K. In the opinion of management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position with respect to the interim condensed consolidated financial statements and the results of its operations for the interim period ended June 30, 2021, have been included. The results of operations for interim periods are not necessarily indicative of the results for a full year. |
Consolidation, Policy [Policy Text Block] | Basis of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of Spine Injury Solutions, Inc. and its wholly owned subsidiary, Quad Video Halo, Inc. All material intercompany balances of transactions have been eliminated upon consolidation. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates |
Revenue [Policy Text Block] | Revenue Recognition The Company’s accounting for revenues is governed by two accounting standards. The Company’s service and product sale revenue are accounted for under ASC 606, Revenue from Contracts with Customers. Additionally, the Company’s QVH rental revenues are accounted for under ASC 842, Leases. Service and Product Sale Revenue Recognition Historically, our net revenues included service revenues that arose from the delivery of medical diagnostic services provided to patients by medical professionals at spine injury diagnostic centers, only after the patients completed and signed required medical and financial paperwork. Service revenues were recorded as net patient service revenues based on variable consideration elements further described below and in Note 4. While we did collect 100% of the accounts on certain patients, our historical collection rate was used to estimate the variable consideration expected and is reflected in the carrying balance of accounts receivable and service revenue recorded. A discount rate of 48%, based on payment history, was used to reduce revenue to 52% of Current Procedural Terminology code rates (“CPT” codes are numbers assigned to every task and service a medical practitioner may provide to a patient including medical, surgical and diagnostic services. CPT codes are developed, maintained and copyrighted by the American Medical Association). Patients were billed at the normal billing amount, based on national averages, for a particular CPT code procedure during the year ended December 31, 2018 and prior years. We recorded no revenue related to medical diagnostic services provided during the three or six months ended June 30, 2021 and 2020, and revenue presented represents adjustments of variable consideration received for procedures performed in years prior to 2019. Service revenue and corresponding accounts receivable are recognized by reference to “net revenue” and “accounts receivable, net” which is defined as gross amounts billed using CPT codes (“gross revenue”) less account discounts that are expected to result when individual cases are ultimately settled, which is the variable consideration associated with this revenue stream. |
Revenue Recognition, Leases [Policy Text Block] | Lease Revenue Rental revenues from operating leases are recognized on a straight-line basis over the term of the lease. Rental billings for periods extending beyond period-end are recorded as deferred income and are recognized in the period earned. For the QVH Leases, rental related services revenues for support, maintenance and video processing, delivery, and installation are lease related because the payments are considered minimum lease payments that are an integral part of the negotiated lease agreement with the customer. These revenues are recognized on a straight-line basis over the term of the lease. As of June 30, 2021, the Company’s leases consisted solely of operating leases. As stated previously, we are uncertain on the effects of the COVID-19 pandemic on our lease revenue going forward. |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments Cash, accounts receivable, accounts payable and accrued liabilities, and notes payable, as reflected in the condensed consolidated financial statements, approximates fair value. Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect these estimates. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Long-Lived Assets |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentrations of Credit Risk |
Share-based Payment Arrangement [Policy Text Block] | Stock Based Compensation |
Income Tax, Policy [Policy Text Block] | Income Taxes We account for income taxes in accordance with the liability method. Under the liability method, deferred assets and liabilities are recognized based upon anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax basis. We establish a valuation allowance to the extent that it is more likely than not that deferred tax assets will not be utilized against future taxable income. |
Income Tax Uncertainties, Policy [Policy Text Block] | Uncertain Tax Positions Accounting Standards Codification “ASC” Topic 740-10-25 defines the minimum threshold a tax position is required to meet before being recognized in the financial statements as “more likely than not” (i.e., a likelihood of occurrence greater than fifty percent). Under ASC Topic 740-10-25, the recognition threshold is met when an entity concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination by the relevant taxing authority. Those tax positions failing to qualify for initial recognition are recognized in the first interim period in which they meet the more likely than not standard or are resolved through negotiation or litigation with the taxing authority, or upon expiration of the statute of limitations. De-recognition of a tax position that was previously recognized occurs when an entity subsequently determines that a tax position no longer meets the more likely than not threshold of being sustained. We are subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, we may incur additional tax expense based upon the outcomes of such matters. In addition, when applicable, we will adjust tax expense to reflect our ongoing assessments of such matters which require judgment and can materially increase or decrease our effective rate as well as impact operating results. Under ASC Topic 740-10-25, only the portion of the liability that is expected to be paid within one year is classified as a current liability. As a result, liabilities expected to be resolved without the payment of cash (e.g. resolution due to the expiration of the statute of limitations) or are not expected to be paid within one year are not classified as current. Estimated interest and penalties, if any, are recognized as income tax expense and tax credits as a reduction in income tax expense. For the three and six months ended June 30, 2021 and 2020, we recognized no estimated interest or penalties as income tax expense. |
Legal Costs, Policy [Policy Text Block] | Legal Costs and Contingencies In the normal course of business, we incur costs to hire and retain external legal counsel to advise us on regulatory, litigation and other matters. We expense these costs as the related services are received. If a loss is considered probable and the amount can be reasonably estimated, we recognize an expense for the estimated loss. If we have the potential to recover a portion of the estimated loss from a third party, we make a separate assessment of recoverability and reduce the estimated loss if recovery is also deemed probable. |
Earnings Per Share, Policy [Policy Text Block] | Net Loss per Share Net loss per common share is presented in accordance with ASC Topic 260, “Earnings per Share,” for all periods presented. During the three and six months ended June 30, 2021 and 2020, common stock equivalents from outstanding stock options, warrants and convertible debt have been excluded from the calculation of the diluted earnings (loss) per share in the condensed consolidated statements of operations, because all such securities were anti-dilutive. The loss per share is calculated by dividing the net loss by the weighted average number of shares outstanding during the periods. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU No. 2016-13 eliminates the probable initial recognition threshold in current U.S. GAAP and, instead, requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. In addition, ASU No. 2016-13 amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. ASU No. 2016-13 was initially effective for annual periods beginning after December 15, 2020, with early application permitted in annual periods beginning after December 15, 2018. In November 2019, the FASB issued ASU 2019-10 which amended the effective date for small reporting companies to fiscal years beginning after December 15, 2022. The amendments of ASU No. 2016-13 should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management is currently evaluating the future impact of ASU No. 2016-13 on the Company’s consolidated financial position, results of operations and disclosures. |
GOING CONCERN CONSIDERATIONS (D
GOING CONCERN CONSIDERATIONS (Details) - USD ($) | Jun. 30, 2021 | Dec. 31, 2020 | Dec. 31, 2009 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Retained Earnings (Accumulated Deficit) | $ (20,282,545) | $ (20,138,182) | $ (15,004,698) |
Retained Earnings, Increase | $ (5,277,847) |
CRITICAL ACCOUNTING POLICIES (D
CRITICAL ACCOUNTING POLICIES (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Account Receivable, Discount Rate | 48.00% | |
Account Receivable, Percentage of Gross Revenue | 52.00% | |
Accounts Receivable, Allowance for Credit Loss | $ 559,007 | $ 585,257 |
ACCOUNTS RECEIVABLE (Details)
ACCOUNTS RECEIVABLE (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2021 | Dec. 31, 2020 | |
Receivables [Abstract] | ||
Account Receivable, Discount Rate | 48.00% | |
Account Receivable, Percentage of Gross Revenue | 52.00% | |
Accounts Receivable, Additional Narrative Disclosure | Historical experience, through 2018, demonstrated that the collection period for individual cases may extend for two years or more. | |
Accounts Receivable, Allowance for Credit Loss | $ 559,007 | $ 585,257 |
TERM LOAN (Details)
TERM LOAN (Details) - USD ($) | Aug. 29, 2020 | Jun. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Aug. 31, 2020 |
TERM LOAN (Details) [Line Items] | |||||
Interest Expense, Debt | $ 6,925 | $ 13,690 | |||
Director [Member] | Secured Debt [Member] | |||||
TERM LOAN (Details) [Line Items] | |||||
Debt Instrument, Collateral | note is collateralized by all of our accounts receivable | ||||
Director [Member] | |||||
TERM LOAN (Details) [Line Items] | |||||
Debt Instrument, Face Amount | $ 610,000 | ||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||||
Notes Payable, Related Parties | $ 450,000 | $ 450,000 | $ 490,000 |
STOCKHOLDERS' EQUITY (Details)
STOCKHOLDERS' EQUITY (Details) - $ / shares | Jun. 30, 2021 | Jan. 19, 2021 | Jan. 18, 2021 | Dec. 31, 2020 |
Stockholders' Equity Note [Abstract] | ||||
Common Stock, Shares Authorized | 250,000,000 | 50,000,000 | 250,000,000 | |
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.001 | $ 0.001 | ||
Common Stock, Shares, Outstanding | 20,240,882 | 20,240,882 | ||
Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | |
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 |
LEASE REVENUES (Details)
LEASE REVENUES (Details) - USD ($) | 6 Months Ended | |
Jun. 30, 2021 | Dec. 31, 2020 | |
LEASE REVENUES (Details) [Line Items] | ||
Operating Lease, Lease Income | $ 16,000 | |
Property, Plant, and Equipment, Lessor Asset under Operating Lease, before Accumulated Depreciation | $ 3,749 | $ 10,959 |
Minimum [Member] | ||
LEASE REVENUES (Details) [Line Items] | ||
Lessor, Operating Lease, Term of Contract | 12 years | |
Maximum [Member] | ||
LEASE REVENUES (Details) [Line Items] | ||
Lessor, Operating Lease, Term of Contract | 36 years |